Analyst Coverage

The following research coverage is provided by independent third-party analysts. Certain reports may be prepared under commissioned research arrangements with Lytix Biopharma. The views and opinions expressed in these reports are those of the respective analysts and do not necessarily reflect the views of Lytix Biopharma.

DNB Carnegie
Klas Palin
klas.palin@dnbcarnegie.se
Access DNB Carnegie research on Lytix

Redeye Equity Research
Richard Ramanius
richard.ramanius@redeye.se
Access Redeye research on Lytix